FDA may revise approval path to avoid some procedures abused by pharmaceutical companies. On June 7, 2021, despite...
Drugs
Bayer terminates $670 million CAR-T partnership with Atara after patient death Bayer terminates $670 million CAR-T partnership with Atara...
Switchable drug and spinal fluid trials may cure Alzheimer's disease New research shows switchable drug and spinal fluid trials...
2022 Alzheimer's Disease Global Drug Development Pipeline Summary 2022 Alzheimer's Disease Global Drug Development Pipeline Summary. Is there any...
Bristol-Myers Squibb OY Combo Bladder Cancer Trial Repeats Mistakes Bristol-Myers Squibb OY Combo Bladder Cancer Trial Repeats Mistakes On May...
FDA lifts clinical hold on Gilead's HIV drug Lenacapavir FDA lifts clinical hold on Gilead's HIV drug Lenacapavir. A...
$157 million: AstraZeneca Introduces Early-stage COVID-19 Drug $157 million: AstraZeneca Introduces Early-stage COVID-19 Drug. On May 17, AstraZeneca announced...
Thailand provides 1 million free cannabis plants to encourage home cultivation. The Thai government will provide 1 million cannabis...
FDA rejects emergency use authorization for fluvoxamine: Ineffective in treating COVID-19 FDA rejects emergency use authorization for fluvoxamine: Ineffective...
AstraZeneca and Fibrogen have serious disagreements: Cooperation on Roxadustat will be broken. AstraZeneca and Fibrogen have serious disagreements:...
2022 Top 10 Most Anticipated New Drugs: 4 have been approved! 2022 Top 10 Most Anticipated New Drugs: 4...
Novartis Sandoz launches first Esbriet generic in US Novartis Sandoz launches first Esbriet generic in US. A few days...
As low as $25/session: Pfizer COVID-19 oral drug Paxlovid generic drug price released As low as $25/session: Pfizer's COVID-19...
FDA approved new oral therapy: Delay functional decline of ALS by 33% FDA approved new oral therapy: Delay functional...
FDA rejected to approve UCB IL-17A monoclonal antibody Bimekizumab FDA rejected to approve UCB IL-17A monoclonal antibody Bimekizumab for...
First time in 10 years: Eli Lilly's GIP/GLP-1 dual-target agonist receives FDA approval First time in 10 years: Eli...
The list of top 10 most expensive drugs in the world The list of top 10 most expensive drugs...
COVID drug patents: NIH MPP and WHO reached licensing agreement to allow pharmaceutical companies in various countries to use. ...
FDA approves Eli Lilly's oral JAK inhibitor Olumiant for hospitalized patients with COVID-19 FDA approves Eli Lilly's oral JAK...
Amylyx released the latest statistical analysis of new ALS drugs after being opposed by FDA panel last month Amylyx...
FDA: No Evidence Supports Continuation of Oral Drugs in Relapsed COVID Patients FDA: No Evidence Supports Continuation of Oral...
Breakthrough: Investigating cancer drug toxicity leads to key discovery Scientific breakthrough in failed clinical trial: Investigating cancer drug toxicity...
AstraZeneca Ultomiris third indication approved by FDA! AstraZeneca Ultomiris third indication approved by FDA! Recently, AstraZeneca announced that the...
How to clear residual cancer cells resistant to targeted therapy? How to clear residual cancer cells resistant to targeted...
What are the tumor immunomodulatory effects of targeted drugs? What are the tumor immunomodulatory effects of targeted drugs?Over the...
Long-term use of folic acid may increase the risk of cancer by 21%? Long-term use of folic acid may...
Eisai/Biogen Announced New Study Results of Lecanemab for Alzheimer's Disease Eisai/Biogen Announced New Study Results of Lecanemab for Alzheimer's...
Solving the Mystery of Radiotherapy Resistance of Brain Metastasis Cancer Cells Nature Medicine: Solving the Mystery of Radiotherapy Resistance...
Biogen withdraws marketing application of Alzheimer's drug Aduhelm from EU Biogen withdraws marketing application of Alzheimer's drug Aduhelm from...
WHO approved Pfizer COVID oral drug Paxlovid for high-risk patients WHO approved Pfizer COVID oral drug Paxlovid for high-risk...
